Notch and the Immune System  by Maillard, Ivan et al.
Immunity, Vol. 19, 781–791, December, 2003, Copyright 2003 by Cell Press
ReviewNotch and the Immune System
Notch1–2 but not Notch3–4 contain a C-terminal tran-Ivan Maillard,1,2 Scott H. Adler,1
scriptional activation domain.and Warren S. Pear2,3,4,*
Notch signaling converts a transmembrane receptor1Department of Medicine
into a nuclear transcriptional coactivator (Figure 1). This2 Abramson Family Cancer Research Institute
multistep process begins with receptor-ligand interac-3 Department of Pathology and Laboratory Medicine
tions between adjacent cells. There are five Notch li-4 Institute for Medicine & Engineering
gands (Jagged1, Jagged2, Delta-like1, Delta-like3, andUniversity of Pennsylvania
Delta-like4) that show limited specificity for individualPhiladelphia, Pennsylvania 19104
Notch receptors ex vivo. Receptor-ligand interaction ini-
tiates two successive cleavages resulting in the release
of ICN. The first cleavage, mediated by an ADAM metal-Notch proteins are used repeatedly to direct develop-
loprotease, occurs external to the transmembrane do-mental cell fate decisions in multiple organs. During
main. The second cleavage occurs within the transmem-hematopoiesis and immune development, Notch is
brane domain and is mediated by a multiprotein complexcritical for T/B lineage specification and for generation
with -secretase activity whose components includeof splenic marginal zone B cells. In early embryonic
presenilin and nicastrin. Blocking -secretase activitydevelopment, Notch is crucial for generating hemato-
with pharmacologic inhibitors or genetic inactivation ofpoietic stem cells. Emerging data suggest that Notch
presenilins or nicastrin prevents Notch signaling (Li etmay also modulate the differentiation and activity of
al., 2003; Zhang et al., 2000). Following cleavage, ICNperipheral T cells. Understanding the specific regula-
translocates to the nucleus, where it binds the transcrip-tion of the Notch pathway in different contexts and its
tion factor CSL (for CBF1/RBP-J in mammals, Suppres-interaction with other signaling pathways remains an
sor of Hairless in Drosophila, and Lag-1 in C. elegans).
important challenge to comprehend the full spectrum
In the absence of ICN, CSL binds corepressors and
of Notch effects. In this review, we critically assess
inhibits transcription. ICN displaces corepressors, re-
recent findings regarding the function of Notch in the
cruits coactivators, and activates transcription. Proteins
hematolymphoid system.
of the Mastermind-like family (MAML) form a complex
with ICN and CSL, and behave as potent transcriptional
Notch signaling is an evolutionarily conserved pathway coactivators, probably by recruiting p300 and other pro-
controlling diverse aspects of development and tissue teins into the transcriptional activation complex (Fryer
homeostasis. The best-characterized function of Notch et al., 2002; Wu et al., 2000, 2002). Additional members
in the immune system is its role in lymphopoiesis, where of this large (1.5 MDa) transcriptional complex are
it is required for T cell commitment from a multipotent likely to be discovered (Jeffries et al., 2002).
progenitor. However, recent findings implicate Notch in The direct effect of Notch activation is increased tran-
additional cell fate decisions: the generation of embry- scription of Notch target genes. These include genes
onic hematopoietic stem cells (HSCs) and splenic mar- that are activated in a variety of cell types by Notch
ginal zone B cells (MZB). In addition, Notch may also signaling, such as the basic-helix-loop-helix transcrip-
influence adult HSC homeostasis and play a role in ma- tion factors of the HES (Hairy-Enhancer of Split) and
HERP (HES-related repressor protein) families that en-ture lymphocytes, although the spectrum and physio-
code transcriptional repressors. Although their preciselogical relevance of these activities require further clarifi-
functions are not known, expression of HES and HERPcation. In this review, we critically discuss the role of
appears split between the descendents of the hemangi-Notch in immune development and function, with an
oblast; HES predominates in hematopoietic lineagesemphasis on recent findings.
and HERP predominates in vascular lineages (reviewed
in Iso et al., 2003). Notch also activates genes that areNotch Signaling
restricted to specific cell types, such as the preTCRMammals have four Notch receptors encoded by four
gene (pT). A major challenge is identifying the spectrumdifferent genes (Notch1–4). Notch receptors are single
of Notch responsive genes, and determining when theirpass transmembrane proteins that are cleaved within
expression reflects Notch activity. This is complicated
the trans-Golgi network during biosynthesis to yield a
by Notch-independent expression of many putative tar-
heterodimeric complex. Extracellular Notch contains
gets, such as HES, and it is not clear that expression
epidermal growth factor-like repeats that bind Notch of a single gene can be used to indicate Notch signaling.
ligands, and LIN12/Notch repeats that likely prevent li- In addition, CSL-independent Notch signaling may oc-
gand-independent signaling. Intracellular Notch (ICN) cur; however, neither the context nor mechanism is
contains several functional domains mediating Notch known (Martinez Arias et al., 2002).
signal transduction. These include the RAM domain In addition to the requirement for receptor-ligand in-
and ankyrin repeats that interact with downstream ef- teractions, Notch signaling is modulated by extracellu-
fector proteins, nuclear localization sequences, and a lar, cytoplasmic, and nuclear proteins (Figure 1). At the
C-terminal PEST sequence regulating protein stability. extracellular level, Notch undergoes posttranslational
modification through the addition of O-linked fucose on
serine and threonine residues within the EGF repeats,*Correspondence: wpear@mail.med.upenn.edu
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Figure 1. Schematic Representation of Notch
Notch is a heterodimeric cell surface receptor. Initiation of signaling requires interaction with one of several ligands (Delta-like or Jagged)
present on an adjacent cell. Posttranslational modification of the extracellular EGF repeats is mediated by the glycosyltransferase Fringe and
serves to modulate receptor-ligand interactions. Following interaction with ligand, Notch is enzymatically cleaved, releasing the cytoplasmic
fragment referred to as ICN (for intracellular Notch). ICN then translocates to the nucleus where it binds to the transcription factor CSL. Under
basal conditions, CSL acts as a transcriptional repressor, but in the presence of ICN it is able to recruit coactivators (such as Mastermind-
like proteins, MAML) and become part of a transcriptional activation complex containing p300. It is not known whether these interactions
occur after or before binding of DNA to CSL. Several Notch target genes have been identified, while many remain unknown. Notch signaling
is also regulated through interactions with other cellular proteins such as Deltex, Nrarp, MINT, and SEL-10.
ICN (intracellular Notch); CSL (CBF1/RBP-Jk, Suppressor of Hairless, Lag-1); MINT (Msx2-interacting nuclear target protein); Dtx (Deltex);
MAML (Mastermind-like proteins); Nrarp (Notch related ankyrin repeat protein); Dll (Delta-like); DSL (Delta, Serrate, Lin); EGFR (Epidermal
growth factor repeats); LNR (Lin, Notch Repeats); ANK (ankyrin repeat domain); and TAD (transactivation domain).
which is essential for Notch signaling (Okajima et al., cell committment (Yun and Bevan, 2003). Deltex is an-
other modulator of Notch signaling that was originally2003). Further modification of these O-linked fucose res-
idues by the addition of N-acetylglucosamine occurs described as a positive Notch regulator in Drosophila.
The precise subcellular localization of Deltex and itsthrough the glycosyltransferase, Fringe (Haltiwanger
and Stanley, 2002). Studies indicate that Fringe differen- mode of interaction with Notch remain controversial. In
mice, transgenic Deltex1 expression antagonizes Notch1tially modulates ligand-mediated signaling, potentiating
Delta-like1 and inhibiting Jagged1 signaling (Hicks et function in the thymus (Izon et al., 2002; Yun and Bevan,
2003) but not Notch2 function during splenic B cell de-al., 2000). Nrarp, a recently described protein that is
highly conserved among vertebrates, is a small protein velopment (Maillard et al., submitted). Moreover, Del-
tex1 is a transcriptional target of Notch signals in devel-containing two ankyrin repeats and a unique domain. It
forms a complex with ICN and CSL and has differential oping thymocytes, where its physiologic role remains
unknown. Msx2-interacting nuclear target protein (MINT,effects on Notch signaling depending upon the system
used. In murine thymocyte progenitors, constitutive Nrarp SHARP in humans) inhibits Notch-mediated transcrip-
tional activation by competing with ICN for binding toexpression blocks Notch signaling and subsequent T
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Figure 2. Notch Signaling during Hematopoietic Development and in the Immune System
Notch signaling plays an important role in cell fate decisions at several steps of hematopoietic and lymphocyte development, such as the
generation of the earliest hematopoietic stem cells in the embryo, the T/B lineage decision in the thymus, and the development of splenic
marginal zone B cells. Other potential roles are controversial (see text). Potential functions in mature lymphocytes have been less well
characterized but may be important as well.
HB (hemangioblast); HSC (hematopoietic stem cell); CLP (common lymphoid progenitor); ETP (early T lineage progenitor); DN (CD4CD8
double-negative thymocytes); T reg (CD4CD25 regulatory T cells); TrB (transitional B cell); FB (follicular B cell); MZB (marginal zone B cell);
and APC (antigen-presenting cell).
CSL (Kuroda et al., 2003; Oswald et al., 2002). MINT/ in their ability to generate hematopoietic colonies. As
these cultures include the AGM region, this result sug-hematopoietic chimeras showed an increased marginal
zone to follicular B cell ratio, suggesting a physiological gests that Notch1 is required for definitive hematopoie-
sis. Primitive hematopoiesis was partially preserved, butrole of MINT as a negative regulator of Notch signaling
in the spleen. However, MINT is also highly expressed cells isolated from both the yolk sac and the AGM region
of Notch1 knockout embryos were unable to rescuein the thymus (Oswald et al., 2002), and whether it func-
tions as a Notch antagonist in this context remains to conditioned newborn recipients, indicating a defect in
HSC activity. Importantly, the phenotype was repro-be demonstrated.
duced in the presence of -secretase inhibitors, but
only until up to E10.5 of embryogenesis, suggesting thatNotch and Hematopoietic Stem Cells
Notch activity is not required once the initial HSC poolRecent studies implicate Notch in the generation of the
has been established. Together, these results suggestearliest embryonic hematopoietic stem cells (HSCs),
a critical function for Notch1 signaling to generate theperhaps as they differentiate from hemangioblasts or
earliest HSCs. Precisely how Notch shapes embryonichemogenic endothelium (Kumano et al., 2003; Figure 2).
HSC development and how it interacts with other actorsDuring embryogenesis, hematopoietic progenitors are
in this process, such as the transcription factors SCL/first found in the extraembryonic yolk sac (YS) in associ-
Tal-1, LMO2, GATA-2, and AML1, awaits further studies.ation with a wave of primitive hematopoiesis, and subse-
Although Notch or CSL knockout studies have notquently in the embryo itself where they give rise to defini-
shown a clear role for Notch in adult HSCs, gain-of-tive hematopoiesis. The aorta-gonad-mesonephros
function experiments show that Notch can promote(AGM) region is an important site for the generation of
adult HSC self-renewal in both mice and humans (Kar-embryonic HSCs and subsequent definitive hematopoi-
anu et al., 2000; Stier et al., 2002; Varnum-Finney et al.,esis. Hirai’s group (Kumano et al., 2003) found that
1998, 2000). This effect is dependent on the presence ofsplancho-pleural explant cultures from Notch1-deficient
but not Notch2-deficient mice were markedly impaired specific cytokines including SCF, IL-6, IL-11, and Flt3L
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(Varnum-Finney et al., 2003). Many of these effects are evidence for the role of Notch in the T/B fate choice is
derived from murine studies. Although Notch1 is likelyreplicated in HSCs of mice expressing a HES-1 trans-
required for T cell commitment in other species (Jalecogene (Kunisato et al., 2003), suggesting that HES-1 may
et al., 2001), whether this always derives from a T/Bmediate part of this activity.
progenitor awaits additional studies.If Notch functions in adult HSC homeostasis, which
On the basis of these results, it was postulated thatcells in the BM activate signaling? BM stromal cells
common lymphoid progenitors (CLPs) colonizing theexpress Notch ligands and could fulfill this function.
thymus are primed for T cell differentiation after receiv-Another possibility is osteoblasts, which are closely as-
ing a signal through the Notch1 receptor, and differenti-sociated with HSCs and support the growth of early
ate by default into the B cell pathway if they fail tohematopoietic progenitors in vitro (Taichman et al.,
receive such a signal. However, it has not yet been1996). Now, Scadden’s group shows that osteoblasts
demonstrated that CLPs, defined as LinIL7RSca-1loexpressing activated Parathyroid Hormone/PTH-related
c-kitlo (Kondo et al., 1997) or LinIL7RAA4.1Sca-1loprotein (PTH/PTHrP) receptors coexpress Jagged1 while
(Miller et al., 2002), are the physiological progenitorsincreasing HSC numbers both in vivo and in long-term
receiving a Notch signal upon thymus colonization. Anculture initiating cell assays (LTC-IC) that measure HSC
alternative to CLPs as physiologic T cell progenitors arefunction (Calvi et al., 2003). In the presence of -secre-
a population termed early T lineage progenitors (ETPs)tase inhibitors, the number of LTC-ICs is reduced to
that exist within Linc-kitCD25 thymocytes (Allmanbaseline levels (but not zero), suggesting that Notch
et al., 2003). ETPs have a much greater ability to producesignaling may influence adult HSCs in specific situations
T cells than CLPs, and are functionally most closely(such as when PTH/PTHrP signals). Although these ob-
related to a subset of pluripotential bone marrow pro-servations do not confirm a physiologic role for Notch
genitors termed LinSca-1c-kit (LSK) rather than toin HSC homeostasis, they open the possibility of using
CLPs (Allman et al., 2003). Thus, physiological T cellPTH/PTHrP and Notch signaling in therapeutic settings
development may be CLP independent. Clearly, it iswhere HSC expansion and engraftment are required,
important to characterize Notch expression and signal-such as bone marrow transplantation.
ing within the different lymphoid progenitors. In addition,Besides Notch, the Sonic hedgehog and Wnt path-
prethymic Notch-mediated T lymphoid commitmentways, as well as members of the Homeobox gene family,
warrants study, since such specification occurs in mu-have been implicated in adult HSC expansion and self-
rine fetal liver (Katsura, 2002) and hematopoietic spleenrenewal (Antonchuk et al., 2002; Bhardwaj et al., 2001;
colonies of bone marrow chimeras (Lancrin et al., 2002).Reya et al., 2003). Deciphering the interactions between
The essential role of Notch1 in the generation of thymus-these pathways will be critical for understanding the
independent intestinal intraepithelial lymphocytes (Wil-regulation of the HSC pool in vivo. Particularly relevant
son et al., 2000) indicates that some extrathymic nichesare studies showing increased Notch1 and HoxB4 ex-
provide the proper signaling environment for Notch-pression following Wnt pathway activation in HSCs, a
mediated T lymphoid commitment in vivo.hint at a hierarchy between these pathways (Reya et
The identity of the relevant Notch ligands in the thy-al., 2003).
mus and their cellular localization remain important
questions. Both Jagged and Delta-like family members
Notch and T Cell Development
are expressed on thymic epithelial cells (see Table 1),
The best-established function of Notch during lymphoid and may be expressed on thymocytes themselves (An-
development is its critical role in the T/B lymphoid cell derson et al., 2001; Felli et al., 1999; Kaneta et al., 2000).
fate decision (Figure 2). Results from both gain- and Notch ligands are also found on thymic dendritic cells;
loss-of-function experiments in mice show that Notch1 however, these cells are unlikely to deliver early signals
signaling is required for the earliest steps of T cell com- during T cell development (Anderson et al., 2001; Yama-
mitment from a progenitor that is capable of forming guchi et al., 2002). Data from Petrie’s group indicate
both T and B cells. Loss-of-function experiments result that blood-borne progenitors enter the thymus in the
in a hypotrophic thymus, lacking T cells and containing perimedullary region of the thymic cortex (Lind et al.,
an excess of B cells, whereas gain-of-function experi- 2001), where they then reside for a significant amount
ments lead to thymic-independent development of im- of time before differentiating and migrating toward outer
mature T cells and loss of B cells. The function of Notch regions of the thymic cortex (Porritt et al., 2003). There-
in the T/B decision is Notch1 specific and CSL depen- fore, it is likely that Notch ligands important for the T
dent (Han et al., 2002). It is not clear whether Notch1 versus B lineage specification are expressed in this
specificity results from unique downstream signals or region.
expression of this receptor in the appropriate progenitor Recent data show that the Notch ligand Dll-1 has the
cell. In support of the latter, constitutive expression of capacity to induce hematopoietic progenitors to adopt
ICN2-4 drives T cell commitment even in the absence a T cell fate in vitro when expressed in bone marrow
of Notch1 signals (I.M. and W.S.P., unpublished data). stromal cell lines (Jaleco et al., 2001; Schmitt and Zun-
Nevertheless, the distinct effects of Notch1 gain- and iga-Pflucker, 2002), while Jagged1 is unable to do so in
loss-of-function approaches on T cell development pro- at least one experimental system (Jaleco et al., 2001).
vide a readout to determine the activity of several Notch These data corroborate other studies demonstrating
modifiers. These studies show that constitutive expres- T cell commitment and differentiation in culture upon
sion of Fringe (Koch et al., 2001), Deltex (Izon et al., expression of constitutively active forms of Notch (De
2002) and Nrarp (Yun and Bevan, 2003) block Notch1 Smedt et al., 2002; Hozumi et al., 2003). These in vitro
studies are complemented by in vivo experiments wheresignals and T cell development. It should be noted that
Review
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Table 1. Expression of Notch Ligands and Notch Family Members in Different Cellular Compartments of the Bone Marrow and Thymus, and
in Peripheral Lymphoid Tissues
A. Bone Marrow and Thymus
BM Thymus
BM Thymic Thymic
BM stroma Progenitors Epithelium DC DN DN1 DN2,3,4 DP 4SP 8SP
J1 d,k,m,o,p md,s b,c,g,l ub e,b,l g g bl b,el el
J2 k r b,g,l u,b b,e,l g g bl e,l e,l
Dll-1 f,kd d b,g,l ub b,l g g bl l l
Dll-3 lg l g g l l l
Dll-4 g g g
N1 d,ms d,m,p,s,t e,h,j,l gj g, j b,e,h,j,l e,h,lj e,h,j,l
N2 d,m,s d,m,p,s,t l e,l e,l e,l
N3 d d e,l e,l e,l e,l
N4 l l l l
B. Peripheral Lymphoid Tissues
Periphery
B T CD4 CD8 DCs
J1 nc,i,m,q m,q i i ni,u
J2 n n n,u
Dll-1 n,q n,q n,u
Dll-3 n n n
Dll-4 n n nu
N1 i,n,t n a,h,i,p h,i,p ni
N2 n,p,t n a,p p n
N3 a
N4 a
Identification at the RNA level through Northern blot or RT-PCR is shown in normal text, at the protein level in italicized text, both in
underlined text.
J1 (Jagged1); J2 (Jagged2); Dll-1/3/4 (Delta-like-1/3/4); N1-4 (Notch1–4); BM (bone marrow); DC (dendritic cell); DN (double-negative thymo-
cytes); DP (double-positive thymocytes); and SP (single-positive thymocytes).
Literature cited: Adler et al., 2003 (a); Anderson et al., 2001 (b); Bash et al., 1999 (c); Bertrand et al., 2000 (d); Felli et al., 1999 (e); Han et al.,
2000 (f); Harman et al., 2003 (g); Hasserjian et al., 1996 (h); Hoyne et al., 2000 (i); Huang et al., 2003 (j); Jones et al., 1998 (k); Kaneta et al.,
2000 (l); Karanu et al., 2000 (m); Kuroda et al., 2003 (n); Li et al., 1998 (o); Ohishi et al., 2000 (p); Singh et al., 2000 (q); Tsai et al., 2000 (r);
Varnum-Finney et al., 1998 (s); Walker et al., 2001 (t); Yamaguchi et al., 2002 (u).
constitutive Dll-4 expression in murine HSCs led to the ligand genes may help resolve existing controversies.
However, such an analysis has been limited by the earlyaccumulation of T lineage cells that likely arose extrathy-
mically (Dorsch et al., 2002; Yan et al., 2001). These lethality of Jagged1, Dll-1, and Dll-3 knockout mice, and
Dll-4 knockouts have not been described. Fetal thymicdata suggest that the only critical property of the thymic
environment for T cell commitment may be its ability to development was studied in Jagged2 knockout mice
which die in the perinatal period (Jiang et al., 1998).efficiently present Notch ligands to thymocyte progeni-
tors, and that Dll-1 or Dll-4 alone in a proper stromal Jagged2 knockout fetuses have a reduced number of
thymic  T cells, but preserved  T cell differentiation.environment may be sufficient to trigger and sustain
T cell development. However, these data have not yet Conditional inactivation of individual Notch ligand genes
will be critical to conclusively establish their respec-conclusively shown that Dll-1 and/or Dll-4 are indeed
the unique ligands used in vivo during thymopoiesis. A tive functions.
Beyond the T versus B lineage specification, Notchpotential confounding factor is the ability of Fringe to
downmodulate Notch activation in a ligand-specific has been postulated to influence several other intra-
thymic processes, including the  versus  T cell lin-way, with inhibition of Jagged1-mediated but not Delta-
mediated Notch1 activation in vitro (Hicks et al., 2000). eage decision, the preTCR checkpoint, and CD4 versus
CD8 development.Guidos and collaborators have shown that transgenic
overexpression of Lunatic Fringe in the thymus causes The effect of Notch on the  versus  T lineage
decision remains controversial. An increased ratio ofa Notch1 loss-of-function phenotype, indirectly sup-
porting a role for Jagged in T cell commitment (Koch et  over  T lineage was observed when Notch1/
heterozygous cells were used with wild-type competi-al., 2001). Understanding Notch regulation by glycosyla-
tion is likely to be complex, as recent data show that, in tors in mixed bone marrow chimeras, suggesting that
Notch1 could favor over  T cell commitment (Wash-Drosophila, overexpression of O-fucosyltransferase-1,
another enzyme that modulates glycosylation of the Notch burn et al., 1997). The underlying mechanism remains
unclear. However, one possibility is that Notch1/ cellsextracellular domain, decreased binding of Notch to
Delta but increased binding to Serrate/Jagged (Okajima are biased to the  lineage due to the effect of Notch
on preTCR signaling (expression of pT and/or VDJ re-et al., 2003). Analysis of individual knockouts of Notch
Immunity
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combination), with more precursors passively adopting bers besides Notch1 can influence the CD4 versus CD8
lineage decision. Mice capable of conditional inactiva-the  lineage due to less efficient  selection. On the
contrary, a recent study showed that overexpression of tion of the CSL gene (Han et al., 2002) should be very
interesting to study in this regard, since elimination ofICN1 in human thymic progenitors caused an increased
ratio of  over  T cells in hybrid human-mouse fetal CSL blocks signaling through all four Notch family mem-
bers. Inactivation of CSL at the DN3 stage with a similarthymic organ cultures (Garcia-Peydro et al., 2003). This
discrepant result was not resolved by inhibiting Notch strategy as described by Wolfer et al. should provide
important evidence to resolve the existing controversy.signaling in the hybrid FTOC, since -secretase inhibi-
tors blocked T cell development without preferential im- Even if the core components of the Notch pathway
are relatively stereotyped, downstream targets differpairment of  differentiation, as would have been ex-
pected from complementary effects in Notch gain- and markedly in various cell types and tissues. Surprisingly
little is known about the genes that are activated uponloss-of-function systems. Whether the expanded 
T cells represented physiological  commitment re- Notch1 stimulation during the T/B lineage decision. This
contrasts markedly with the wealth of information avail-mains to be demonstrated, since a large proportion of
these cells were CD8 and not DN  T cells. Earlier able on the transcription factors required to initiate and
maintain B lineage commitment (Schebesta et al., 2002).results from Robey’s group showed decreased DN 
but increased CD8  T cells in the thymi of lck-ICN1 One of the reasons for this knowledge gap is related to
the technical difficulties in accessing the relevant raretransgenic mice (Washburn et al., 1997). Finally, condi-
tional inactivation of Notch1 driven by the expression population of thymic progenitors, in comparison to early
B cell precursors. Among potential downstream targets,of Cre under a proximal lck promoter impaired  T cell
differentiation while preserving normal numbers of  the basic-helix-loop-helix transcription factors HES-1
and HES-5 are Notch-regulated in many organs. Analy-T cells (Wolfer et al., 2002). These results may indicate
that Notch1 does not influence  lineage choice once sis of HES-1 knockout mice revealed abnormalities in
thymic development, although the findings do not phe-the T/B lineage decision has been made, or that defini-
tive  commitment occurred prior to a decline in Notch1 nocopy the Notch1 knockout phenotype (Kaneta et al.,
2000; Tomita et al., 1999). Indeed, the differentiationprotein levels after inactivation of the Notch1 gene in
this experimental system. block could be overridden by injecting more progenitors
with subsequent normal thymocyte development (Ka-Other data from the same conditional knockout mice
strongly indicate that Notch1 actively modulates the neta et al., 2000). These findings are consistent with a
role for HES-1 in the proliferation of early thymic progeni-preTCR checkpoint. In the absence of Notch1, CD25bright
DN3 cells accumulated, similar to mice with impaired tors, but indicate that HES-1 itself does not recapitulate
Notch1 signaling during the T/B lineage decision. Similarcomponents of the pre-TCR such as pT/, TCR/,
or RAG-1/ mice. There was also an abnormal DN4 data have not been reported for HES-5 or other HES
family members. CD25 and pTmay also be direct Notchpopulation that did not express a cytoplasmic TCR
chain and had thus aberrantly survived  selection. Al- transcriptional targets; however, their expression does
not appear to be coincident with the time of the T/B cellthough VDJ recombination was impaired in the absence
of Notch1, pT expression seemed intact, a surprising fate choice.
As in other lineage decisions, Notch-induced T cellresult since pT is likely to be a direct Notch transcrip-
tional target (Reizis and Leder, 2002). These data, how- commitment is likely to be accompanied by inhibition
of alternative cell fates. For example, Notch1 signalingever, do not rule out an essential role for Notch1 in the
initial opening of the pT locus, before inactivation of inhibits E2A signaling, an activity that may be important
for the loss of B cell potential (Izon et al., 2002; Ordentlichthe Notch1 gene in lck-Cre x Notch1lox/lox mice, while
other proteins would be required at later time points to et al., 1998). An interesting reciprocal interaction was
found in early B cell progenitors, where Pax5 directlymaintain its expression. Control of vestigial expression
in Drosophila wing development is an example of such inhibited Notch1 transcription in mice in which the Pax5
gene was knocked into the Ikaros locus and expresseda regulatory mechanism (Kim et al., 1996). Overall, the
complex phenotype of lck-Cre x Notch1lox/lox mice sug- widely during hematopoietic development (Souabni et
al., 2002). Although inhibition of T cell development wasgests that Notch1 contributes to both VDJ recombina-
tion at the TCR locus and thus to the proper expression observed in the thymi of these mice, intrathymic B cell
development was not described. Furthermore, extrathy-of a preTCR, as well as to the physical elimination of
cells which fail  selection. mic T cell development was not observed in Pax5/
mice, a finding that might have resulted from the lossAnother controversial area is the function of Notch in
the CD4 versus CD8 lineage decision. The mechanisms of Pax5-mediated Notch inhibition. Nevertheless, these
findings illustrate how transcription factors promote dif-underlying this decision are complex (reviewed by
Singer, 2002). Gain-of-function experiments have sug- ferentiation to one lineage, while inhibiting alternative
cell fates.gested that Notch activation increases the ratio of CD8
over CD4 SP cells (Robey et al., 1996). In contrast, Altogether, much remains to be learned about Notch-
regulated transcriptional control of T cell commitment,Wolfer and collaborators have not observed any devia-
tion from the normal CD4:CD8 ratio in a carefully con- and how this control is connected to the other pathways
known to regulate early T cell differentiation. For exam-trolled study of mice with a conditional inactivation of
Notch1 at the DN3 stage, using a CD4-Cre transgenic ple, GATA-3 and Wnt are key players in the regulatory
network of early T cell development (Rothenberg, 2002;mouse strain (Wolfer et al., 2001). These results indicate
either that the findings of gain-of-function experiments Ting et al., 1996; van de Wetering et al., 2002), and links
to the Notch pathway would be interesting to explore.are nonphysiological or that other Notch family mem-
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Notch and Peripheral T Cells Notch signaling can induce the appearance of regulatory
Notch receptors are present in both CD4 and CD8 T cells (Hoyne et al., 2000; Yvon et al., 2003). In studies
peripheral T cells (Table 1), and expression of all four using either murine or human cells, exposure of T cells
receptors is upregulated following T cell activation (Ad- to APCs engineered to express Jagged1 generated T
ler et al., 2003; Palaga et al., 2003). After antigenic stimu- regulatory cells capable of transferring inhibitory activity
lation of CD4 T cells, Notch1 activation occurred, as to naive cultures (Hoyne et al., 2000; Yvon et al., 2003).
demonstrated by reagents detecting the cleaved (acti- Although wild-type APCs express several Notch ligands
vated) protein (Adler et al., 2003). Furthermore, Notch (Jagged1, Jagged2, Dll-1, and Dll-4; Table 1), their ability
ligand exposure induces HES-1 and Deltex1 expression to induce T regulatory cells via Notch activation has not
(Palaga et al., 2003; Yvon et al., 2003). In addition, the been demonstrated. Thus, the physiologic relevance of
relative abundance of Notch4 mRNA, which is present these studies awaits confirmation. Recently, a novel de-
at very low levels during T cell development, is markedly ndritic cell subset (CD11clo and CD45RBhi plasmacytoid
increased following T cell activation; however, it remains DCs) was found to promote the appearance of regula-
to be determined if Notch4 protein expression and activ- tory T cells (Wakkach et al., 2003). Whether or not this
ity are similarly increased. Together, these reports sug- DC population expresses Notch ligands and can induce
gest a potential role for Notch in T cell immune re- Notch signaling is unknown.
sponses.
This potential role was confirmed by two recent stud- Notch and B Cells
ies showing that Notch signaling enhanced T cell activa- Notch2 is the predominant Notch receptor in B cells,
tion (Adler et al., 2003; Palaga et al., 2003). In loss-of- with widespread expression throughout B cell develop-
function experiments using -secretase inhibitors, T cell ment and in peripheral B cell subsets (Kuroda et al.,
proliferation and cytokine production (IL-2 and IFN) 2003; Saito et al., 2003). Overexpression of ICN in vivo
were inhibited (Adler et al., 2003; Palaga et al., 2003). results in profound inhibition of B cell development (Ka-
Palaga et al. also investigated T cell activation in Notch1 wamata et al., 2002; Pui et al., 1999). Furthermore, ex-
antisense transgenic mice and found diminished IL-2 pression of ICN in various chicken, mouse, and human
and IFN secretion from transgenic T cells. Since a simi- B cell lines results in growth arrest and apoptosis (Mori-
lar phenotype was not reported in Notch1 conditional mura et al., 2000). Whether Notch plays analogous roles
knockout mice (see below), it is possible that the Notch1 in vivo at physiological levels remains to be explored.
antisense construct had broader effects. In contrast, con- Analysis of CSL and more recently Notch2 conditional
stitutive ICN1 expression enhanced CD25 expression knockout mice revealed a critical role for Notch2 in the
in primary CD4 T cells and their proliferation when generation of marginal zone B (MZB) cells (Saito et al.,
exposed to subthreshold levels of peptide or IL-2 (Adler 2003; Tanigaki et al., 2002). The mechanisms through
et al., 2003). Together, these data provide the first evi- which Notch exerts this important function and the pre-
dence that Notch signaling has the potential to augment cise cellular intermediates during MZB development are
T cell function. The addition of the Notch pathway to the poorly understood. MZB cells are best characterized in
numerous effects of other costimulatory signals might
mice as a subset of nonrecirculating mature splenic B
provide a means to either enhance or terminate T cell
cells localized in the marginal zone, expressing a distinct
immune responses. The physiological relevance and
immunophenotype (sIgMhiCD21hiCD23lo). They exhibit
mechanisms of this effect await further studies.
robust proliferation upon LPS stimulation, secrete anti-In contrast, genetic studies using Notch1 conditional
bodies early during immune responses, and may func-knockout mice have not identified a requirement for
tion in the immune response to blood-borne pathogensNotch1 in peripheral CD4 or CD8 T cells, as peripheral
(reviewed in Martin and Kearney, 2002). Although someT cell responses were normal in lymphocytes derived
of these properties are shared with B1 B cells, the influ-from Notch1lox/lox x CD4-Cre mice (Radtke et al., 2002).
ence of Notch on the B1 B cell pool is controversial. NoAlthough these studies suggest that Notch1 alone is not
reduction in peritoneal B1 B cells was observed in bothrequired for peripheral T cell responses, it does not
CSL and Notch2 conditional knockout mice, while arule out a role for other Notch receptors, a possibility
significant decrease in the peritoneal B1a and to a lessersuggested by the increased expression of all four recep-
extent the B1b population was reported recently bytors in activated T cells (Adler et al., 2003). In fact, results
Klug’s group in Notch2/ mice (Witt et al., 2003). Afrom Yasutomo’s group (Maekawa et al., 2003) suggest
potential explanation to resolve this controversy maythat signaling through Notch3 may be required to gener-
be that gene inactivation during fetal life is required toate an optimal Th1 response. Utilizing both gain- and
see an effect on B1 B cells.loss-of-function approaches, this group showed that
Multiple pathways influence the generation and/or re-activation of Notch signaling by Dll-1 in nonpolarizing
tention of MZB cells. The BCR itself is likely involved, asconditions, as well as in Th1 and Th2 polarizing condi-
perturbations in the nature and strength of BCR signalstions, enhanced -interferon and downregulated IL-4
affect recruitment to the MZB compartment (reviewedproduction. Notch signaling may be upstream of T-bet
in Martin and Kearney, 2002). The absolute number oftranscription, and retroviral expression of ICN3 but not
B cells may also be important, as several genetic modelsICN1 recapitulated the ability of Dll-1 to induce -inter-
with impaired B cell development, such as mice withferon. Although this work requires confirmation in the
impaired signaling through the IL-7R or preBCR com-knockout mice, it suggests a potential role for Notch
plex, display a relative increase in MZB cell numbers,during cell fate decisions in mature CD4 T cells.
possibly due to preferential filling of the MZB compart-An additional role for Notch in modulating T cell re-
sponses is suggested by several studies showing that ment (reviewed in Martin and Kearney, 2002). Specific
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non-BCR signaling pathways are also important as Ai- in vivo, identifying the downstream targets of Notch
signaling, and understanding the functions of Notcholos knockout mice, and mice lacking components of
the NFB pathway have a decreased MZB cell pool modifiers. In addition, there are few antibodies that rec-
ognize Notch signaling components and improved re-(Cariappa et al., 2000, 2001). Retention of the cells in
the MZ also plays a role, as antibody-mediated blockade agents would lead to advances afforded by image analy-
sis. Although it is not clear if Notch-specific reagentsof LFA-1 and 41 integrins in vivo led to physical re-
lease of B cells from the MZ (Lu and Cyster, 2002). If will be clinically useful, the potential use of -secretase
inhibitors to treat Alzheimer’s disease emphasizes theand how Notch2 interacts with these different pathways
remains to be determined. Conceptually, Notch could importance of understanding the effects of Notch signal-
ing in the immune system.function by modulating other pathways or it could act
as a gatekeeper to the MZB cell pool, independently of
other signals. Among potential effects of Notch2 activa- Acknowledgments
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